Impact of total versus subtotal thyroidectomy on calcium metabolism and bone mineral density in premenopausal women

Journal of Laryngology and Otology

Volumn 123, Issue 4, 2009, Pages 434-438

  Tunca, F ^a   Senyurek, Y G ^a   Terzioglu, T ^a   Tanakol, R ^a   Tezelman, S ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Bone density; Thyroidectomy; Thyroxine

Indexed keywords

ALKALINE PHOSPHATASE; CALCITONIN; CALCIUM; PARATHYROID HORMONE; PHOSPHATE; THYROTROPIN; THYROXINE;

ARTICLE; BONE DENSITY; CALCIUM BLOOD LEVEL; CALCIUM METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GOITER; HUMAN; INTERMETHOD COMPARISON; POSTOPERATIVE PERIOD; PREMENOPAUSE; SUBTOTAL THYROIDECTOMY; THYROIDECTOMY; ADULT; METABOLISM; METHODOLOGY; NODULAR GOITER; PELVIC GIRDLE; PHOTON ABSORPTIOMETRY; PHYSIOLOGY; RADIOGRAPHY; SPINE;

ABSORPTIOMETRY, PHOTON; ADULT; BONE DENSITY; CALCIUM; FEMALE; GOITER, NODULAR; HUMANS; PELVIC BONES; PREMENOPAUSE; SPINE; THYROIDECTOMY; THYROXINE;

EID: 68049110508     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215108003630     Document Type: Article

References (34)

1. Frilling A, Hertl M. Endemic goiter and benign multinodular goiter. In: Doherty GM, Skogseid B, eds. Surgical Endocrinology. Philadelphia, Lippincott Williams & Wilkins, 2001;37-45
2. Delbridge L, Guinea AI, Reeve TS. Total thyroidectomy for bilateral benign multinodular goiter: effect of changing practice. Arch Surg 1999;134:1389-93
3. Pappalardo G, Guadalaxara A, Frattaroli FM, Illomei G, Falaschi P. Total compared with subtotal thyroidectomy in benign nodular disease: personal series and review of published reports. Eur J Surg 1998;164:501-6
4. Reeve TS, Delbridge L, Brady P, Crummer P, Smyth C. Secondary thyroidectomy: a twenty-year experience. World J Surg 1988;12:449-53
5. McDermott MT, Kidd GS, Blue P, Ghaed V, Hofeldt FD. Reduced bone mineral content in totally thyroidectomized patients: possible effect of calcitonin deficiency. J Clin Endocrinol Metab 1983;56:936-9
6. Scheider P,Berger P,Kruse K,Borner W. Effect of calcitonin deficiency on bone density and bone turnover in totally thyroidectomized patients. J Endocrinol Invest 1991;14:935-42
7. Capelli C, Cottarelli C, Cumetti D, Agosti B, Gandossi E, Rizzoni D, Agabiti Rosei E et al. Bone density and mineral metabolism in calcitonin-deficiency patients. Minerva Endocrinol 2004;29:1-10
8. Sianesi M, Cervellin GF, Palummeri E, De Lorenzis GF, Ghirarduzzi A, Chiampo L et al. Calcitonin deficit syndrome in thyroidectomized patients. Ital J Surg Sci 1985;15:145-8
9. Lowery WD, Thomas CG Jr, Ambrey BJ, Rosenstein BD, Talmage RV. The late effect of subtotal thyroidectomy and radioactive iodine therapy on calcitonin secretion and bone mineral density in women treated for Graves' disease. Surgery 1986;100:1142-9
10. Duncan WE, Chang A, Solomon B, Wartowsky L. Influence of clinical characteristics and parameters associated with thyroid hormone therapy on bone mineral density of women treated with thyroid hormone. Thyroid 1994;4:143-4
11. Diamond T, Nery L, Hales I. A therapeutic dilemma: suppressive doses of thyroxine significantly reduce bone mineral measurements in both premenopausal and post-menopausal women with thyroid carcinoma. J Clin Endocrinol Metab 1991;72(6):1184-8
12. Giannini S, Nobile M, Sartori L, Binotto P, Ciuffreda M, Gemo G et al. Bone density and mineral metabolism in thyroidectomized patients teated with long term L-thyroxine. Clin Sci 1994;87:593-7
13. Korsic M, Cvijetic S, Dekanic-Ozegovic D, Bolanca S, Kozic B. Bone mineral density in patients on long term therapy with levothyroxine [in Croatian]. Lijec Vjesn 1998;120:103-5
14. Garton M, Reid I, Loveridge N, Robins S, Murchison L, Bekett G et al. Bone mineral density and metabolism in premenopausal women taking L-thyroxine therapy. Clin Endocrinol 1994;41:747-55
15. Guo CY,Weetman AP, Eastell R. Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine. Clin Endocrinol 1997;46:301-7
16. Kung AW, Lorentz T, Tam SC. Thyroxine suppressive therapy decreases bone mineral density in postmenopausal women. Clin Endocrinol 1993;39:535-40
17. Mirzaei S, Krotla G, Knoll P, Koriska K, Kohn H. Possible effect of calcitonin deficiency on bone mass after subtotal thyroidectomy [in German]. Acta Med Austrica 1999;26: 29-31
18. Hurley DL, Tiegs RD, Wahner HW, Heath H 3rd. Axial and apendicular bone mineral density in patients with long term deficiency or excess of calcitonin. N Engl J Med 1987;317:537-41
19. Lakatos P, Tarjan G, Merei J, Foldes J, Hollo I. Androgens and bone mineral content in patients with subtotal thyroidectomy for benign nodular disease. Acta Med Hng 1989;46: 297-305
20. Marcocci C, Golia F, Bruno-Bossio G, Vignali E, Pichera A. Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women. J Clin Endocrinol Metab 2004;78:818-22
21. Greenspan SL, Greenspan FS, Resnick NM, Block JE, Friedlander AL, Genant HK. Skeletal integrity in premenopausal and postmenopausal women receiving long-term L-thyroxine therapy. Am J Med 1991;91:5-14
22. Sijanovic S, Karner I. Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone. Medscape Womens Health ejournal 2001;6:3
23. Chen CH, Chen JF, Yang BY, Liu RT, Tung SC, Chien WY et al. Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma. J Formos Med Assoc 2004;103:442- 7
24. Baran DT. Hyperthyroidism, thyroid hormone replacement and osteoporosis. In: Favus MJ, ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 3rd edn. Philadelphia: Lippincott Raven, 1996:286-8
25. Franklyn JA, Betteridge J, Daykin J, Holder R, Oates GD, Parle JV et al. Long-term thyroxine treatment and bone mineral density. Lancet 1992;340:9-13
26. Gonzales DC, Mautalen CA, Correa PH, el Tamer E, el Tamer S. Bone mass in totally thyroidectomized patients. Role of calcitonin deficiency and exogenous thyroid treatment. Acta Endocrinol 1991;124:521-5
27. Quan ML, Pasieka JL, Rorstad O. Bone mineral density in well-differentiated thyroid cancer patients treated with suppressive thyroxine: a systematic overview of the literature. J Surg Oncol 2002;79:62-9
28. Sugino K, Kure Y, Suzuki A, Sekino H, Iwasaki H, Goto H et al. Bone metabolism in thyroidectomized patients - evaluation of bone mineral content by quantitative CT [in Japanese]. Nippon Geka Gakkai Zasshi 1990;91: 500-7
29. Becker KL, Snider RH, Moore CF, Monoghan KG, Silva OL. Calcitonin in extrathyroidal tissues of man. Acta Endocrinol 1979;92:746-51
30. Hirsch PF, Lester GE, Talmage RV. Calcitonin an enigmatic hormone: does it have a function? J Musculoskelet Neuronal Interact 2001;1:299-305
31. Silva O, Wisneski LA, Cyrus J, Snider RH, Moore CF, Becker KL. Calcitonin thyroidectomized patients. Am J Med Sci 1978;275:159-64
32. Lopez Alvarez MB, Hawkins F, Rigopoulou D, Martinez G, Jodar E, Estenoz J et al. The risk factors and bone mineral density in women on long-term levothyroxine treatment. Med Clin 1999;30:85-9
33. Nguyen TT, Heath H 3rd, Bryant SC, O'Fallon WM, Melton LJ 3rd. Fractures after thyroidectomy in men: a population-based cohort study. J Bone Miner Res 1997; 12:1092-9
34. Pouillés JM, Trémollieres FA, Ribot C. Osteoporosis in otherwise healthy perimenopausal and early postmenopausal women: physical and biochemical characteristics. Osteoporosis Int 2006;17:1954-9